A Novel Targeted Therapy of Leydig and Granulosa Cell Tumors through the Luteinizing Hormone Receptor Using a Hecate-Chorionic Gonadotropin β Conjugate in Transgenic Mice

This publication has 46 references indexed in Scilit:

• New Lytic Peptides Based on thed,l-Amphipathic Helix Motif Preferentially Kill Tumor Cells Compared to Normal Cells
  Biochemistry, 2003
• A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice
  Journal of Biological Chemistry, 2003
• Effects of a Lytic Peptide Conjugated to β hCG on Ovarian Cancer: Studies in Vitro and in Vivo
  Gynecologic Oncology, 2002
• Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin α Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects1
  Biology of Reproduction, 2001
• Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening
  The Lancet, 2000
• The mouse inhibin α-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice
  Molecular and Cellular Endocrinology, 1996
• Peptide Antibiotics and Their Role in Innate Immunity
  Annual Review of Immunology, 1995
• A receptor binding site identified in the region 81–95 of the β-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG)
  Molecular and Cellular Endocrinology, 1993
• Establishment of gonadotropin-responsive murine leydig tumor cell line.
  The Journal of cell biology, 1982
• Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis.
  Journal of Histochemistry & Cytochemistry, 1978